Quantinno Capital Management LP grew its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 119.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 18,709 shares of the company's stock after purchasing an additional 10,183 shares during the quarter. Quantinno Capital Management LP's holdings in Azenta were worth $935,000 as of its most recent filing with the SEC.
A number of other large investors have also made changes to their positions in the stock. Boothbay Fund Management LLC boosted its holdings in Azenta by 8.4% during the fourth quarter. Boothbay Fund Management LLC now owns 6,571 shares of the company's stock valued at $329,000 after purchasing an additional 509 shares in the last quarter. Picton Mahoney Asset Management boosted its holdings in shares of Azenta by 305.7% in the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after acquiring an additional 532 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of Azenta by 14.9% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock worth $225,000 after acquiring an additional 576 shares in the last quarter. KBC Group NV boosted its holdings in shares of Azenta by 48.5% in the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after acquiring an additional 698 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund boosted its holdings in shares of Azenta by 7.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 10,700 shares of the company's stock worth $535,000 after acquiring an additional 702 shares in the last quarter. Institutional investors and hedge funds own 99.08% of the company's stock.
Azenta Price Performance
Shares of Azenta stock traded down $0.44 on Wednesday, hitting $27.28. 408,204 shares of the company's stock traded hands, compared to its average volume of 691,271. The firm's 50-day moving average price is $28.65 and its two-hundred day moving average price is $40.72. The stock has a market capitalization of $1.25 billion, a PE ratio of -9.16 and a beta of 1.64. Azenta, Inc. has a one year low of $23.91 and a one year high of $63.58.
Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. During the same quarter in the prior year, the firm posted $0.06 EPS. The business's revenue was up 5.1% on a year-over-year basis. On average, analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.
Analyst Ratings Changes
AZTA has been the topic of several recent analyst reports. TD Cowen raised Azenta to a "hold" rating in a report on Thursday, February 27th. Evercore ISI boosted their price objective on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th. Finally, Needham & Company LLC dropped their price objective on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th.
Read Our Latest Report on AZTA
About Azenta
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Read More

Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.